Announcement Date: January 1, 2016
Lawsuits continue to pile up against J&J. At least 3 recent verdicts have given hope to more than 1,700 Risperdal gynecomastia lawsuits pending in Pennsylvania’s Philadelphia Court of Common Pleas. The cases have been consolidated to form a mass tort program – all plaintiffs allege that gynecomastia and other adverse events were caused by Risperdal; that Janssen may have concealed knowledge of the side effects; and that it failed to adequately warn of these risks, thereby claiming the company was negligent (Risperdal Litigation case number 100300296).